Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.
暂无分享,去创建一个
J. Gribben | D. Neuberg | J. Ritz | D. Fisher | A. Freedman | P. Mauch | R. Soiffer | R. Schlossman | P. Mauch | K. Marcus | E. Alyea | K. Marcus | J. Gribben | R. Soiffer | I. Webb | D. Fisher | K. Anderson | I. Webb | K. Anderson
[1] R. Soiffer,et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] G. Hill,et al. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. , 2000, Blood.
[3] D. Hallahan,et al. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies , 2000, Bone Marrow Transplantation.
[4] C. Lawton. Total-body irradiation for bone marrow transplantation. , 1999, Oncology.
[5] K. Sullivan,et al. Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia , 1998 .
[6] N. Ueno,et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Nagler,et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.
[8] S. Mackinnon,et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. , 1998, Blood.
[9] E. Estey,et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. , 1997, Blood.
[10] A. Freedman,et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. , 1992, Journal of Clinical Oncology.
[11] B. Shank,et al. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. , 1992, Blood.
[12] F. Appelbaum,et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. , 1991, Blood.
[13] F. Appelbaum,et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.
[14] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[15] W. Lutz,et al. Design and characteristics of a facility for total-body and large-field irradiation. , 1988, International Journal of Radiation Oncology, Biology, Physics.
[16] R. Hoffmann,et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. , 1988 .
[17] J. Ritz,et al. Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis. , 1986, Transplantation.
[18] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .